Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group
Objectives Gender‐related factors can influence management decisions, treatment outcomes and the overall long‐term wellbeing of people living with HIV (PLWH). The Women Against Viruses in Europe (WAVE) Working Group was established to promote the health and wellbeing of women living with HIV (WLWH)....
Gespeichert in:
| Veröffentlicht in: | HIV medicine 2018-02, Vol.19 (2), p.167-173 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 173 |
|---|---|
| container_issue | 2 |
| container_start_page | 167 |
| container_title | HIV medicine |
| container_volume | 19 |
| creator | Kowalska, JD Aebi‐Popp, K Loutfy, M Post, FA Perez‐Elias, MJ Johnson, M Mulcahy, F d'Arminio Monforte, A. Branco, T. Latysheva, K. Seed, A. Verluyten, J. Geretti, A. M. Dagnall, R. Anderson, J. De Jesus Albino Caixa, U. Gatell, J. M. Gjonbalaj, A. Gokengin, A. D. Haberl, A. Lyons, F. Mardarescu, M. Oprea, C. Papadopulous, A. Stoycheva, M. Voronin, E. Youle, M. Dixon‐Williams, E. Konopnicki, D. Krasniqi, V. Lacombe, K. Mussini, C. Boffito, M. Battegay, M. Friis‐MØller, N. Gilleece, Y. Mackie, N. Tariq, S. |
| description | Objectives
Gender‐related factors can influence management decisions, treatment outcomes and the overall long‐term wellbeing of people living with HIV (PLWH). The Women Against Viruses in Europe (WAVE) Working Group was established to promote the health and wellbeing of women living with HIV (WLWH). WAVE is part of the European AIDS Clinical Society (EACS) and organizes annual workshops to discuss different issues in the management of WLWH.
Methods
In 2016, 34 WAVE members including community representatives, HIV clinicians and researchers met to discuss standards of care for WLWH and to review current guidelines. Participants focused on three different themes: (1) access to and engagement and retention in care; (2) monitoring of women on antiretroviral therapy and management of comorbidities; and (3) review of EACS treatment guidelines.
Results
Five priority areas for optimizing the care of WLWH were identified: (1) psychosocial aspects of HIV diagnosis and care; (2) mental health and wellbeing; (3) pharmacokinetics, toxicity and tolerability of antiretroviral therapy; (4) coinfections and comorbidities; and (5) sexual and reproductive health. WAVE recommendations are provided for each of these areas, and gaps in knowledge and needs for changes in currently existing standards are discussed.
Conclusions
This position statement provides an overview of the key recommendations to optimize the care of WLWH that emerged during the 2016 WAVE workshop. |
| doi_str_mv | 10.1111/hiv.12565 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1986601182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1986601182</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3885-dfe787d2e2d234dbf52057fadeba85c789da56053b1834ff62b912486a8d1903</originalsourceid><addsrcrecordid>eNp1kE1PwyAYgInROJ0e_AOGxJOHTqCFUm9mmR-JiR6WeWzogJW5lQp0iz_A_y3d1JtcIOF5nzd5ALjAaITjuanNZoQJZfQAnOCM8QSTIj3cvbOEMEYG4NT7JUI4Twt0DAakwLTgDJ-Ar1dn1zaYZgFrs6ihD6KRwkkPrYZz4RTU1sGtXasGrsym57Ym1PDxaXYLW-tNMLbpp4KKSIA66mCoFXzbjdwthGl8gDPjOq88NA2cdM62_b97720PznbtGTjSYuXV-c89BNP7yXT8mDy_PDyN756Teco5TaRWOc8lUUSSNJOVpgTRXAupKsHpPOeFFJQhmlaYp5nWjFQFJhlngktcoHQIrvba1tmPTvlQLm3nmrixxDEHQxhzEqnrPTV31nundNk6sxbus8So7HuXsXe56x3Zyx9jV62V_CN_A0fgZg9szUp9_m8qY9C98huoeYs3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1986601182</pqid></control><display><type>article</type><title>Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Kowalska, JD ; Aebi‐Popp, K ; Loutfy, M ; Post, FA ; Perez‐Elias, MJ ; Johnson, M ; Mulcahy, F ; d'Arminio Monforte, A. ; Branco, T. ; Latysheva, K. ; Seed, A. ; Verluyten, J. ; Geretti, A. M. ; Dagnall, R. ; Anderson, J. ; De Jesus Albino Caixa, U. ; Gatell, J. M. ; Gjonbalaj, A. ; Gokengin, A. D. ; Haberl, A. ; Lyons, F. ; Mardarescu, M. ; Oprea, C. ; Papadopulous, A. ; Stoycheva, M. ; Voronin, E. ; Youle, M. ; Dixon‐Williams, E. ; Konopnicki, D. ; Krasniqi, V. ; Lacombe, K. ; Mussini, C. ; Boffito, M. ; Battegay, M. ; Friis‐MØller, N. ; Gilleece, Y. ; Mackie, N. ; Tariq, S.</creator><creatorcontrib>Kowalska, JD ; Aebi‐Popp, K ; Loutfy, M ; Post, FA ; Perez‐Elias, MJ ; Johnson, M ; Mulcahy, F ; d'Arminio Monforte, A. ; Branco, T. ; Latysheva, K. ; Seed, A. ; Verluyten, J. ; Geretti, A. M. ; Dagnall, R. ; Anderson, J. ; De Jesus Albino Caixa, U. ; Gatell, J. M. ; Gjonbalaj, A. ; Gokengin, A. D. ; Haberl, A. ; Lyons, F. ; Mardarescu, M. ; Oprea, C. ; Papadopulous, A. ; Stoycheva, M. ; Voronin, E. ; Youle, M. ; Dixon‐Williams, E. ; Konopnicki, D. ; Krasniqi, V. ; Lacombe, K. ; Mussini, C. ; Boffito, M. ; Battegay, M. ; Friis‐MØller, N. ; Gilleece, Y. ; Mackie, N. ; Tariq, S. ; Women Against Viruses in Europe (WAVE) Working Group</creatorcontrib><description>Objectives
Gender‐related factors can influence management decisions, treatment outcomes and the overall long‐term wellbeing of people living with HIV (PLWH). The Women Against Viruses in Europe (WAVE) Working Group was established to promote the health and wellbeing of women living with HIV (WLWH). WAVE is part of the European AIDS Clinical Society (EACS) and organizes annual workshops to discuss different issues in the management of WLWH.
Methods
In 2016, 34 WAVE members including community representatives, HIV clinicians and researchers met to discuss standards of care for WLWH and to review current guidelines. Participants focused on three different themes: (1) access to and engagement and retention in care; (2) monitoring of women on antiretroviral therapy and management of comorbidities; and (3) review of EACS treatment guidelines.
Results
Five priority areas for optimizing the care of WLWH were identified: (1) psychosocial aspects of HIV diagnosis and care; (2) mental health and wellbeing; (3) pharmacokinetics, toxicity and tolerability of antiretroviral therapy; (4) coinfections and comorbidities; and (5) sexual and reproductive health. WAVE recommendations are provided for each of these areas, and gaps in knowledge and needs for changes in currently existing standards are discussed.
Conclusions
This position statement provides an overview of the key recommendations to optimize the care of WLWH that emerged during the 2016 WAVE workshop.</description><identifier>ISSN: 1464-2662</identifier><identifier>EISSN: 1468-1293</identifier><identifier>DOI: 10.1111/hiv.12565</identifier><identifier>PMID: 29159861</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Disease Management ; Drug Monitoring ; Drug therapy ; Europe ; Female ; Guidelines ; Health care ; Health Services Accessibility ; HIV ; HIV Infections - diagnostic imaging ; HIV Infections - drug therapy ; Human immunodeficiency virus ; Humans ; Management ; Mental disorders ; Mental Health ; Optimization ; Pharmacokinetics ; Pharmacology ; Reproductive Health ; Sexually transmitted diseases ; Standard of Care ; STD ; Therapy ; Toxicity ; Treatment Outcome ; Viruses ; women ; Women Against Viruses in Europe (WAVE) ; Working groups ; Workshops</subject><ispartof>HIV medicine, 2018-02, Vol.19 (2), p.167-173</ispartof><rights>2017 British HIV Association</rights><rights>2017 British HIV Association.</rights><rights>HIV Medicine © 2018 British HIV Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3885-dfe787d2e2d234dbf52057fadeba85c789da56053b1834ff62b912486a8d1903</citedby><cites>FETCH-LOGICAL-c3885-dfe787d2e2d234dbf52057fadeba85c789da56053b1834ff62b912486a8d1903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhiv.12565$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhiv.12565$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29159861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kowalska, JD</creatorcontrib><creatorcontrib>Aebi‐Popp, K</creatorcontrib><creatorcontrib>Loutfy, M</creatorcontrib><creatorcontrib>Post, FA</creatorcontrib><creatorcontrib>Perez‐Elias, MJ</creatorcontrib><creatorcontrib>Johnson, M</creatorcontrib><creatorcontrib>Mulcahy, F</creatorcontrib><creatorcontrib>d'Arminio Monforte, A.</creatorcontrib><creatorcontrib>Branco, T.</creatorcontrib><creatorcontrib>Latysheva, K.</creatorcontrib><creatorcontrib>Seed, A.</creatorcontrib><creatorcontrib>Verluyten, J.</creatorcontrib><creatorcontrib>Geretti, A. M.</creatorcontrib><creatorcontrib>Dagnall, R.</creatorcontrib><creatorcontrib>Anderson, J.</creatorcontrib><creatorcontrib>De Jesus Albino Caixa, U.</creatorcontrib><creatorcontrib>Gatell, J. M.</creatorcontrib><creatorcontrib>Gjonbalaj, A.</creatorcontrib><creatorcontrib>Gokengin, A. D.</creatorcontrib><creatorcontrib>Haberl, A.</creatorcontrib><creatorcontrib>Lyons, F.</creatorcontrib><creatorcontrib>Mardarescu, M.</creatorcontrib><creatorcontrib>Oprea, C.</creatorcontrib><creatorcontrib>Papadopulous, A.</creatorcontrib><creatorcontrib>Stoycheva, M.</creatorcontrib><creatorcontrib>Voronin, E.</creatorcontrib><creatorcontrib>Youle, M.</creatorcontrib><creatorcontrib>Dixon‐Williams, E.</creatorcontrib><creatorcontrib>Konopnicki, D.</creatorcontrib><creatorcontrib>Krasniqi, V.</creatorcontrib><creatorcontrib>Lacombe, K.</creatorcontrib><creatorcontrib>Mussini, C.</creatorcontrib><creatorcontrib>Boffito, M.</creatorcontrib><creatorcontrib>Battegay, M.</creatorcontrib><creatorcontrib>Friis‐MØller, N.</creatorcontrib><creatorcontrib>Gilleece, Y.</creatorcontrib><creatorcontrib>Mackie, N.</creatorcontrib><creatorcontrib>Tariq, S.</creatorcontrib><creatorcontrib>Women Against Viruses in Europe (WAVE) Working Group</creatorcontrib><title>Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group</title><title>HIV medicine</title><addtitle>HIV Med</addtitle><description>Objectives
Gender‐related factors can influence management decisions, treatment outcomes and the overall long‐term wellbeing of people living with HIV (PLWH). The Women Against Viruses in Europe (WAVE) Working Group was established to promote the health and wellbeing of women living with HIV (WLWH). WAVE is part of the European AIDS Clinical Society (EACS) and organizes annual workshops to discuss different issues in the management of WLWH.
Methods
In 2016, 34 WAVE members including community representatives, HIV clinicians and researchers met to discuss standards of care for WLWH and to review current guidelines. Participants focused on three different themes: (1) access to and engagement and retention in care; (2) monitoring of women on antiretroviral therapy and management of comorbidities; and (3) review of EACS treatment guidelines.
Results
Five priority areas for optimizing the care of WLWH were identified: (1) psychosocial aspects of HIV diagnosis and care; (2) mental health and wellbeing; (3) pharmacokinetics, toxicity and tolerability of antiretroviral therapy; (4) coinfections and comorbidities; and (5) sexual and reproductive health. WAVE recommendations are provided for each of these areas, and gaps in knowledge and needs for changes in currently existing standards are discussed.
Conclusions
This position statement provides an overview of the key recommendations to optimize the care of WLWH that emerged during the 2016 WAVE workshop.</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Disease Management</subject><subject>Drug Monitoring</subject><subject>Drug therapy</subject><subject>Europe</subject><subject>Female</subject><subject>Guidelines</subject><subject>Health care</subject><subject>Health Services Accessibility</subject><subject>HIV</subject><subject>HIV Infections - diagnostic imaging</subject><subject>HIV Infections - drug therapy</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Management</subject><subject>Mental disorders</subject><subject>Mental Health</subject><subject>Optimization</subject><subject>Pharmacokinetics</subject><subject>Pharmacology</subject><subject>Reproductive Health</subject><subject>Sexually transmitted diseases</subject><subject>Standard of Care</subject><subject>STD</subject><subject>Therapy</subject><subject>Toxicity</subject><subject>Treatment Outcome</subject><subject>Viruses</subject><subject>women</subject><subject>Women Against Viruses in Europe (WAVE)</subject><subject>Working groups</subject><subject>Workshops</subject><issn>1464-2662</issn><issn>1468-1293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1PwyAYgInROJ0e_AOGxJOHTqCFUm9mmR-JiR6WeWzogJW5lQp0iz_A_y3d1JtcIOF5nzd5ALjAaITjuanNZoQJZfQAnOCM8QSTIj3cvbOEMEYG4NT7JUI4Twt0DAakwLTgDJ-Ar1dn1zaYZgFrs6ihD6KRwkkPrYZz4RTU1sGtXasGrsym57Ym1PDxaXYLW-tNMLbpp4KKSIA66mCoFXzbjdwthGl8gDPjOq88NA2cdM62_b97720PznbtGTjSYuXV-c89BNP7yXT8mDy_PDyN756Teco5TaRWOc8lUUSSNJOVpgTRXAupKsHpPOeFFJQhmlaYp5nWjFQFJhlngktcoHQIrvba1tmPTvlQLm3nmrixxDEHQxhzEqnrPTV31nundNk6sxbus8So7HuXsXe56x3Zyx9jV62V_CN_A0fgZg9szUp9_m8qY9C98huoeYs3</recordid><startdate>201802</startdate><enddate>201802</enddate><creator>Kowalska, JD</creator><creator>Aebi‐Popp, K</creator><creator>Loutfy, M</creator><creator>Post, FA</creator><creator>Perez‐Elias, MJ</creator><creator>Johnson, M</creator><creator>Mulcahy, F</creator><creator>d'Arminio Monforte, A.</creator><creator>Branco, T.</creator><creator>Latysheva, K.</creator><creator>Seed, A.</creator><creator>Verluyten, J.</creator><creator>Geretti, A. M.</creator><creator>Dagnall, R.</creator><creator>Anderson, J.</creator><creator>De Jesus Albino Caixa, U.</creator><creator>Gatell, J. M.</creator><creator>Gjonbalaj, A.</creator><creator>Gokengin, A. D.</creator><creator>Haberl, A.</creator><creator>Lyons, F.</creator><creator>Mardarescu, M.</creator><creator>Oprea, C.</creator><creator>Papadopulous, A.</creator><creator>Stoycheva, M.</creator><creator>Voronin, E.</creator><creator>Youle, M.</creator><creator>Dixon‐Williams, E.</creator><creator>Konopnicki, D.</creator><creator>Krasniqi, V.</creator><creator>Lacombe, K.</creator><creator>Mussini, C.</creator><creator>Boffito, M.</creator><creator>Battegay, M.</creator><creator>Friis‐MØller, N.</creator><creator>Gilleece, Y.</creator><creator>Mackie, N.</creator><creator>Tariq, S.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>201802</creationdate><title>Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group</title><author>Kowalska, JD ; Aebi‐Popp, K ; Loutfy, M ; Post, FA ; Perez‐Elias, MJ ; Johnson, M ; Mulcahy, F ; d'Arminio Monforte, A. ; Branco, T. ; Latysheva, K. ; Seed, A. ; Verluyten, J. ; Geretti, A. M. ; Dagnall, R. ; Anderson, J. ; De Jesus Albino Caixa, U. ; Gatell, J. M. ; Gjonbalaj, A. ; Gokengin, A. D. ; Haberl, A. ; Lyons, F. ; Mardarescu, M. ; Oprea, C. ; Papadopulous, A. ; Stoycheva, M. ; Voronin, E. ; Youle, M. ; Dixon‐Williams, E. ; Konopnicki, D. ; Krasniqi, V. ; Lacombe, K. ; Mussini, C. ; Boffito, M. ; Battegay, M. ; Friis‐MØller, N. ; Gilleece, Y. ; Mackie, N. ; Tariq, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3885-dfe787d2e2d234dbf52057fadeba85c789da56053b1834ff62b912486a8d1903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Disease Management</topic><topic>Drug Monitoring</topic><topic>Drug therapy</topic><topic>Europe</topic><topic>Female</topic><topic>Guidelines</topic><topic>Health care</topic><topic>Health Services Accessibility</topic><topic>HIV</topic><topic>HIV Infections - diagnostic imaging</topic><topic>HIV Infections - drug therapy</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Management</topic><topic>Mental disorders</topic><topic>Mental Health</topic><topic>Optimization</topic><topic>Pharmacokinetics</topic><topic>Pharmacology</topic><topic>Reproductive Health</topic><topic>Sexually transmitted diseases</topic><topic>Standard of Care</topic><topic>STD</topic><topic>Therapy</topic><topic>Toxicity</topic><topic>Treatment Outcome</topic><topic>Viruses</topic><topic>women</topic><topic>Women Against Viruses in Europe (WAVE)</topic><topic>Working groups</topic><topic>Workshops</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kowalska, JD</creatorcontrib><creatorcontrib>Aebi‐Popp, K</creatorcontrib><creatorcontrib>Loutfy, M</creatorcontrib><creatorcontrib>Post, FA</creatorcontrib><creatorcontrib>Perez‐Elias, MJ</creatorcontrib><creatorcontrib>Johnson, M</creatorcontrib><creatorcontrib>Mulcahy, F</creatorcontrib><creatorcontrib>d'Arminio Monforte, A.</creatorcontrib><creatorcontrib>Branco, T.</creatorcontrib><creatorcontrib>Latysheva, K.</creatorcontrib><creatorcontrib>Seed, A.</creatorcontrib><creatorcontrib>Verluyten, J.</creatorcontrib><creatorcontrib>Geretti, A. M.</creatorcontrib><creatorcontrib>Dagnall, R.</creatorcontrib><creatorcontrib>Anderson, J.</creatorcontrib><creatorcontrib>De Jesus Albino Caixa, U.</creatorcontrib><creatorcontrib>Gatell, J. M.</creatorcontrib><creatorcontrib>Gjonbalaj, A.</creatorcontrib><creatorcontrib>Gokengin, A. D.</creatorcontrib><creatorcontrib>Haberl, A.</creatorcontrib><creatorcontrib>Lyons, F.</creatorcontrib><creatorcontrib>Mardarescu, M.</creatorcontrib><creatorcontrib>Oprea, C.</creatorcontrib><creatorcontrib>Papadopulous, A.</creatorcontrib><creatorcontrib>Stoycheva, M.</creatorcontrib><creatorcontrib>Voronin, E.</creatorcontrib><creatorcontrib>Youle, M.</creatorcontrib><creatorcontrib>Dixon‐Williams, E.</creatorcontrib><creatorcontrib>Konopnicki, D.</creatorcontrib><creatorcontrib>Krasniqi, V.</creatorcontrib><creatorcontrib>Lacombe, K.</creatorcontrib><creatorcontrib>Mussini, C.</creatorcontrib><creatorcontrib>Boffito, M.</creatorcontrib><creatorcontrib>Battegay, M.</creatorcontrib><creatorcontrib>Friis‐MØller, N.</creatorcontrib><creatorcontrib>Gilleece, Y.</creatorcontrib><creatorcontrib>Mackie, N.</creatorcontrib><creatorcontrib>Tariq, S.</creatorcontrib><creatorcontrib>Women Against Viruses in Europe (WAVE) Working Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>HIV medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kowalska, JD</au><au>Aebi‐Popp, K</au><au>Loutfy, M</au><au>Post, FA</au><au>Perez‐Elias, MJ</au><au>Johnson, M</au><au>Mulcahy, F</au><au>d'Arminio Monforte, A.</au><au>Branco, T.</au><au>Latysheva, K.</au><au>Seed, A.</au><au>Verluyten, J.</au><au>Geretti, A. M.</au><au>Dagnall, R.</au><au>Anderson, J.</au><au>De Jesus Albino Caixa, U.</au><au>Gatell, J. M.</au><au>Gjonbalaj, A.</au><au>Gokengin, A. D.</au><au>Haberl, A.</au><au>Lyons, F.</au><au>Mardarescu, M.</au><au>Oprea, C.</au><au>Papadopulous, A.</au><au>Stoycheva, M.</au><au>Voronin, E.</au><au>Youle, M.</au><au>Dixon‐Williams, E.</au><au>Konopnicki, D.</au><au>Krasniqi, V.</au><au>Lacombe, K.</au><au>Mussini, C.</au><au>Boffito, M.</au><au>Battegay, M.</au><au>Friis‐MØller, N.</au><au>Gilleece, Y.</au><au>Mackie, N.</au><au>Tariq, S.</au><aucorp>Women Against Viruses in Europe (WAVE) Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group</atitle><jtitle>HIV medicine</jtitle><addtitle>HIV Med</addtitle><date>2018-02</date><risdate>2018</risdate><volume>19</volume><issue>2</issue><spage>167</spage><epage>173</epage><pages>167-173</pages><issn>1464-2662</issn><eissn>1468-1293</eissn><abstract>Objectives
Gender‐related factors can influence management decisions, treatment outcomes and the overall long‐term wellbeing of people living with HIV (PLWH). The Women Against Viruses in Europe (WAVE) Working Group was established to promote the health and wellbeing of women living with HIV (WLWH). WAVE is part of the European AIDS Clinical Society (EACS) and organizes annual workshops to discuss different issues in the management of WLWH.
Methods
In 2016, 34 WAVE members including community representatives, HIV clinicians and researchers met to discuss standards of care for WLWH and to review current guidelines. Participants focused on three different themes: (1) access to and engagement and retention in care; (2) monitoring of women on antiretroviral therapy and management of comorbidities; and (3) review of EACS treatment guidelines.
Results
Five priority areas for optimizing the care of WLWH were identified: (1) psychosocial aspects of HIV diagnosis and care; (2) mental health and wellbeing; (3) pharmacokinetics, toxicity and tolerability of antiretroviral therapy; (4) coinfections and comorbidities; and (5) sexual and reproductive health. WAVE recommendations are provided for each of these areas, and gaps in knowledge and needs for changes in currently existing standards are discussed.
Conclusions
This position statement provides an overview of the key recommendations to optimize the care of WLWH that emerged during the 2016 WAVE workshop.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29159861</pmid><doi>10.1111/hiv.12565</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1464-2662 |
| ispartof | HIV medicine, 2018-02, Vol.19 (2), p.167-173 |
| issn | 1464-2662 1468-1293 |
| language | eng |
| recordid | cdi_proquest_journals_1986601182 |
| source | Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Acquired immune deficiency syndrome AIDS Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Disease Management Drug Monitoring Drug therapy Europe Female Guidelines Health care Health Services Accessibility HIV HIV Infections - diagnostic imaging HIV Infections - drug therapy Human immunodeficiency virus Humans Management Mental disorders Mental Health Optimization Pharmacokinetics Pharmacology Reproductive Health Sexually transmitted diseases Standard of Care STD Therapy Toxicity Treatment Outcome Viruses women Women Against Viruses in Europe (WAVE) Working groups Workshops |
| title | Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T10%3A42%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Promoting%20high%20standards%20of%20care%20for%20women%20living%20with%20HIV:%20position%20statement%20from%20the%20Women%20Against%20Viruses%20in%20Europe%20Working%20Group&rft.jtitle=HIV%20medicine&rft.au=Kowalska,%20JD&rft.aucorp=Women%20Against%20Viruses%20in%20Europe%20(WAVE)%20Working%20Group&rft.date=2018-02&rft.volume=19&rft.issue=2&rft.spage=167&rft.epage=173&rft.pages=167-173&rft.issn=1464-2662&rft.eissn=1468-1293&rft_id=info:doi/10.1111/hiv.12565&rft_dat=%3Cproquest_cross%3E1986601182%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1986601182&rft_id=info:pmid/29159861&rfr_iscdi=true |